China Pharma Holdings vs Therapeuticsmd
China Pharma Holdings is the larger business, with $4.1m of revenue in fiscal 2025 against $3.0m for Therapeuticsmd (1.4 times as much). Therapeuticsmd grew faster (71.6% against -8.5%). Therapeuticsmd kept more of each dollar of sales as profit: a net margin of -18.8% against -76.9%. Therapeuticsmd carries less debt relative to equity (0.0% against 14.5%).
| Latest fiscal year | China Pharma HoldingsCPHI, 2025 | TherapeuticsmdTXMD, 2025 |
|---|---|---|
| Revenue | $4.1m | $3.0m |
| Revenue growth | -8.5% | 71.6% |
| Net income | −$3.2m | −$569,000 |
| Operating margin | -78.2% | -145.3% |
| Net margin | -76.9% | -18.8% |
| Return on equity | -20.9% | -2.1% |
| Free cash flow | $88,937 | $2.5m |
| Cash | $345,112 | $7.5m |
| Total debt | $3.3m | $0 |
| Debt to equity | 14.5% | 0.0% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 221 | — |
| Market value | $24.7m | $20.9m |
| Price vs our value range | — | — |
| Moat score | 26 (Weak) | 22 (Weak) |
| Insider trades, 12 months | 0 buys, 0 sales | 1 buys, 0 sales |